Advertisement

PharmacoEconomics & Outcomes News

, Volume 841, Issue 1, pp 3–3 | Cite as

Apixaban cost-effective option for stroke prevention in AF in Spain

Clinical study
  • 5 Downloads

Reference

  1. Oyaguez I, et al. Cost-Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke Prevention. PharmacoEconomics-Open : 31 Oct 2019. Available from: URL: https://doi.org/10.1007/s41669-019-00186-7

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations